title: The IPCS Collaborative Study on Neurobehavioral Screening Methods: III. Results of proficiency studies. Steering Group.
abstract: The goal of the IPCS Collaborative Study on Neurobehavioral Screening Methods was to determine the intra- and inter-laboratory reliability of a functional observational battery (FOB) and an automated assessment of motor activity in eight laboratories world-wide. The first phase of the Collaborative Study involved training the participants: evidence of training was then evaluated using positive-control compounds. The positive-control studies required the laboratories to identify, using the FOB, specific neurotoxic syndromes produced by acute exposure to p,p'-DDT, parathion, and by short-term repeated dosing with acrylamide. For the sake of expediency, only one dose of each chemical was used instead of collecting dose-response data. Motor activity test chambers were not of uniform design. The laboratories were therefore required to demonstrate adequate sensitivity by the ability to detect statistically-significant activity increases and decreases produced by triadimefon and chlorpromazine, respectively, following acute administration of a range of doses. The resulting FOB and motor activity data showed variability in the magnitude of effects obtained: some of these differences were attributed to miscommunications, difficulties with the techniques or protocol, or the limitations of having only one dose. All laboratories, however, successfully met the criteria set forth by the Study Steering Committee.
authors.affiliation: Neurotoxicology Division, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA.
authors.forename: V C
authors.initials: VC
authors.lastname: Moser
authors.forename: G C
authors.initials: GC
authors.lastname: Becking
authors.forename: V
authors.initials: V
authors.lastname: Cuomo
authors.forename: E
authors.initials: E
authors.lastname: Frantík
authors.forename: B M
authors.initials: BM
authors.lastname: Kulig
authors.forename: R C
authors.initials: RC
authors.lastname: MacPhail
authors.forename: H A
authors.initials: HA
authors.lastname: Tilson
authors.forename: G
authors.initials: G
authors.lastname: Winneke
authors.forename: W S
authors.initials: WS
authors.lastname: Brightwell
authors.forename: R
authors.initials: R
authors.lastname: Cagiano
authors.forename: M W
authors.initials: MW
authors.lastname: Gill
authors.forename: G C
authors.initials: GC
authors.lastname: Haggerty
authors.forename: M
authors.initials: M
authors.lastname: Hornychová
authors.forename: J
authors.initials: J
authors.lastname: Lammers
authors.forename: J J
authors.initials: JJ
authors.lastname: Larsen
authors.forename: K L
authors.initials: KL
authors.lastname: McDaniel
authors.forename: B K
authors.initials: BK
authors.lastname: Nelson
authors.forename: G
authors.initials: G
authors.lastname: Ostergaard
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D004353:Drug Evaluation, Preclinical / Q000379:methods; D017408:Guidelines as Topic; D008297:Male; D051381:Rats; D015203:Reproducibility of Results; D018675:Toxicity Tests / Q000379:methods*; D015262:Xenobiotics / Q000633:toxicity*
chemical_list: D015262:Xenobiotics